Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
429K
-
Shares change
-
-46.4K
-
Total reported value, excl. options
-
$616K
-
Value change
-
-$82.3K
-
Number of buys
-
2
-
Number of sells
-
-5
-
Price
-
$1.44
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q2 2020
12 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q2 2020.
ProPhase Labs, Inc. - COM (PRPH) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 429K shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (201K shares), Bank of New York Mellon Corp (116K shares), NORTHERN TRUST CORP (41.2K shares), PNC Financial Services Group, Inc. (25.4K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (18.9K shares), COMMONWEALTH EQUITY SERVICES, LLC (17.9K shares), UBS Group AG (6.93K shares), MORGAN STANLEY (850 shares), ROYAL BANK OF CANADA (630 shares), and VICTORY CAPITAL MANAGEMENT INC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.